4-(6-pyridin-3-yl-pyridazin-3-yl)-1, 4-diazabyciclo[3. 2. 2]nonane fumaric acid salt | 695183-37-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-(6-pyridin-3-yl-pyridazin-3-yl)-1, 4-diazabyciclo[3. 2. 2]nonane fumaric acid salt
• 英文别名: 4-(6-pyridin-3-yl-pyridazin-3-yl)-1,4-diazabicyclo[3.2.2]nonane fumaric acid salt；(E)-but-2-enedioic acid;4-(6-pyridin-3-ylpyridazin-3-yl)-1,4-diazabicyclo[3.2.2]nonane
• CAS: 695183-37-0
• 化学式: C₄H₄O₄*C₁₆H₁₉N₅
• 分子量: 397.434
• InChiKey: GAHYMRVUHGGLKQ-WLHGVMLRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.53
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  120
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  3-奎宁环酮肟 在 四(三苯基膦)钯 sodium hydroxide 、 lithium aluminium tetrahydride 、 PPA 、 potassium carbonate 、 1,3-丙二醇 作用下， 以 1,4-二氧六环 、 甲醇 、 乙醚 、 水 为溶剂， 反应 21.83h， 生成 4-(6-pyridin-3-yl-pyridazin-3-yl)-1, 4-diazabyciclo[3. 2. 2]nonane fumaric acid salt
  参考文献：
  名称：

  Novel diazabicyclic biaryl derivatives

  摘要：

  该发明涉及新型的二氮杂双环联苯衍生物，发现它们在尼古丁乙酰胆碱受体上是胆碱能配体，并且调节单胺受体和转运体。由于它们的药理特性，该发明的化合物可能对治疗与中枢神经系统（CNS）的胆碱能系统、外周神经系统（PNS）、平滑肌收缩相关的疾病或紊乱、内分泌疾病或紊乱、神经退行性疾病或紊乱、炎症相关的疾病或紊乱、疼痛以及由于滥用化学物质终止而引起的戒断症状可能有用。

  公开号：

  US20040127491A1

文献信息

• [EN] 1,4-DIAZABICYCLO (3,2,2)NONANE DERIVATIVES, PREPARATION AND THERAPEUTICAL USE THEREOF<br/>[FR] DERIVES DE 1,4-DIAZABICYCLO (3,2,2)NONANE, PREPARATION ET UTILISATIONS THERAPEUTIQUES DE CES DERIVES
  申请人：NEUROSEARCH AS

  公开号：WO2004043960A1

  公开（公告）日：2004-05-27

  This invention relates to novel diazabicyclic biaryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  这项发明涉及新型的二氮杂双环联苯衍生物，发现它们在尼古丁酰胆碱受体上是胆碱能配体，并且可以调节单胺受体和转运体。由于它们的药理特性，该发明的化合物可能对治疗与中枢神经系统（CNS）的胆碱能系统、外周神经系统（PNS）、平滑肌收缩相关的疾病或疾病、内分泌疾病或疾病、神经退行性疾病或疾病、炎症、疼痛以及因滥用化学物质而引起的戒断症状相关的疾病或疾病可能有用。
• Diazabicyclic biaryl derivatives
  申请人：Neurosearch A/S

  公开号：US07223753B2

  公开（公告）日：2007-05-29

  This invention relates to novel diazabicyclic biaryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  本发明涉及新型的二氮杂双环联苯衍生物，这些衍生物被发现是乙酰胆碱受体的胆碱能配体，并且是单胺类受体和转运体的调节剂。由于它们的药理特性，本发明的化合物可能对与中枢神经系统（CNS）和外周神经系统（PNS）的胆碱能系统有关的疾病或疾病，与平滑肌收缩有关的疾病或疾病，内分泌疾病或疾病，与神经退行性有关的疾病或疾病，与炎症、疼痛和化学物质滥用终止引起的戒断症状有关的疾病或疾病的治疗有用。